Ledger.Open graph →
SEC Form D · Amendment · filed July 22, 2020

Lucy Therapeutics, Inc

Offering
$4.5M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Amy Ripka · Cambridge, MAExec · DirectorAnn G. Dewitt · Cambridge, MADirectorJohn Ripple · Cambridge, MADirectorSallie C. Squires · San Francisco, CADirectorBreellen Loughlin · Fitchburg, WIExec · DirectorKarin L. Brotman · San Francisco, CADirectorJorge Olson · San Diego, CAExec · DirectorNeville Pearson · San Diego, CADirectorSandro Piancone · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗